Emerging therapies in rosacea

Alison Layton, Diane Thiboutot

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Rosacea is a common skin disorder with multiple symptoms. The emergence of research that furthers understanding of pathophysiological mechanisms has created new targets for disease treatment. Specifically, there is a need for new treatments that address the various erythematic symptoms associated with rosacea. Systemic and topical therapies have both yielded positive results in treating rosacea with various medications. Subantimicrobial-dose doxycycline is one such promising treatment. Development of novel products in the near future should help achieve more satisfactory outcomes for patients.

Original languageEnglish (US)
JournalJournal of the American Academy of Dermatology
Volume69
Issue number6 SUPPL.1
DOIs
StatePublished - Dec 1 2013

Fingerprint

Rosacea
Doxycycline
Therapeutics
Skin
Research

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

@article{a05357d3151c45f0b87858a5bd5aeb79,
title = "Emerging therapies in rosacea",
abstract = "Rosacea is a common skin disorder with multiple symptoms. The emergence of research that furthers understanding of pathophysiological mechanisms has created new targets for disease treatment. Specifically, there is a need for new treatments that address the various erythematic symptoms associated with rosacea. Systemic and topical therapies have both yielded positive results in treating rosacea with various medications. Subantimicrobial-dose doxycycline is one such promising treatment. Development of novel products in the near future should help achieve more satisfactory outcomes for patients.",
author = "Alison Layton and Diane Thiboutot",
year = "2013",
month = "12",
day = "1",
doi = "10.1016/j.jaad.2013.04.041",
language = "English (US)",
volume = "69",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "6 SUPPL.1",

}

Emerging therapies in rosacea. / Layton, Alison; Thiboutot, Diane.

In: Journal of the American Academy of Dermatology, Vol. 69, No. 6 SUPPL.1, 01.12.2013.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Emerging therapies in rosacea

AU - Layton, Alison

AU - Thiboutot, Diane

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Rosacea is a common skin disorder with multiple symptoms. The emergence of research that furthers understanding of pathophysiological mechanisms has created new targets for disease treatment. Specifically, there is a need for new treatments that address the various erythematic symptoms associated with rosacea. Systemic and topical therapies have both yielded positive results in treating rosacea with various medications. Subantimicrobial-dose doxycycline is one such promising treatment. Development of novel products in the near future should help achieve more satisfactory outcomes for patients.

AB - Rosacea is a common skin disorder with multiple symptoms. The emergence of research that furthers understanding of pathophysiological mechanisms has created new targets for disease treatment. Specifically, there is a need for new treatments that address the various erythematic symptoms associated with rosacea. Systemic and topical therapies have both yielded positive results in treating rosacea with various medications. Subantimicrobial-dose doxycycline is one such promising treatment. Development of novel products in the near future should help achieve more satisfactory outcomes for patients.

UR - http://www.scopus.com/inward/record.url?scp=84887928396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887928396&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2013.04.041

DO - 10.1016/j.jaad.2013.04.041

M3 - Article

C2 - 24229638

AN - SCOPUS:84887928396

VL - 69

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 6 SUPPL.1

ER -